HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Epstein Barré virus-negative diffuse large B-cell lymphoma in an HIV-infected man with a durable complete remission on highly active antiretroviral therapy alone.

Abstract
We report a unique case of a human immunodeficiency virus (HIV)-infected man with Epstein-Barré virus (EBV) negative diffuse large B-cell lymphoma (DLBCL) that responded solely to highly active antiretroviral therapy (HAART). Our patient presented with a retroperitoneal mass, high viral load, CD4 288 and began therapy with HAART with marked improvement of symptoms. The patient declined chemotherapy since he felt better after HAART, and rescanning at that time demonstrated marked improvement of the lymphoma on HAART alone. Viral load became undetectable, CD4 450 by 8 weeks. By 6 months, the patient had a complete remission verified by positron emission tomography/computed tomography (PET/CT) and has remained in remission to date on HAART alone. We postulate that HIV infection directly precipitated the lymphoma.
AuthorsAnita Koszyk-Szewczyk, Michael Bayerl, John Zurlo, Joseph J Drabick
JournalSouthern medical journal (South Med J) Vol. 103 Issue 1 Pg. 76-80 (Jan 2010) ISSN: 1541-8243 [Electronic] United States
PMID19996843 (Publication Type: Case Reports, Journal Article)
Topics
  • Antiretroviral Therapy, Highly Active
  • HIV Infections (complications, drug therapy)
  • Herpesvirus 4, Human
  • Humans
  • Lymphoma, Large B-Cell, Diffuse (complications, drug therapy, virology)
  • Male
  • Middle Aged
  • Remission Induction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: